Regulatory Approval

A top engineering prize honors John Donoghue for BrainGate, a technology that lets the mind control machines, offering new hope for paralysis and ALS.

A new report reveals 97% of investigations rely on smartphone data, but agencies are struggling with the digital deluge and AI policy roadblocks.

New data reveals Orca-T cell therapy boosts survival and cuts complications in blood cancer, as the company prepares for a potential FDA approval this year.

Winners Inc. launches MeVu, a 'Tinder for sports trading,' but can it navigate a complex legal landscape and turn the company's fortunes around?

The world's largest prediction market is upgrading its financial backbone, swapping bridged assets for Circle's native USDC to enhance security and trust.

A new partnership aims to overcome the hurdles of at-home testing by combining instrument-free PCR with advanced enzymes for rapid, reliable results.

A new survey reveals 84% of firms doubt they can pass an AI compliance audit, exposing a massive security gap as autonomous agent adoption surges.

A landmark deal sees US tech giant CrowdStrike partner with Aramco to build a national cybersecurity defense, securing Saudi Arabia's AI-driven future.

Empyrean Medical Systems partners with Wide Code to bring its advanced MOVHEET radiation therapy to Greater China, a strategic move in a booming oncology market.

Despite product withdrawals, a lack of regulation and the long latency of asbestos-related diseases mean the danger from talc exposure is far from over.

Pluristyx and Solesis launch a 'three-in-one' kit with nearly 100% efficiency in iPSC transfection, tackling a major bottleneck in organoid research.

As open finance regulations loom and sophisticated fraud surges, a new partnership aims to build trust and security into the core of financial data sharing.

With major drug approvals on the horizon, Nuvalent's leadership will detail its strategy for its next-gen cancer therapies at an influential investor summit.

The UK-based firm's STIMULAN® is now the only EU-certified calcium matrix for combined antibiotic use, revolutionizing bone infection treatment.

Positive study results for Alvotech's Entyvio biosimilar could disrupt the IBD market, promising lower costs for a blockbuster chronic care treatment.

Brad Karp's 18-year reign ends abruptly after his ties to Jeffrey Epstein create a 'distraction,' paving the way for dealmaker Scott Barshay to lead.

With its lead drug MOLBREEVI under FDA review, Savara's upcoming investor talks are a critical test of its path from clinical trials to market.

Toray's next-gen material has achieved a key certification, promising to slash costs and accelerate the development of future aircraft and defense systems.

A new framework published in a Nature journal measures AI safety, not just accuracy. A specialized model has already outperformed systems from Google and OpenAI.

AIROS Medical's FDA-cleared ARTAIRA device brings non-invasive PAD therapy home as global cases are projected to surge past 360 million by 2050.